PharmAsia Market Study May 2000

 


Regular Price: USD 1,000

Special Price USD 700

30% OFF

* Required Fields

Regular Price: USD 1,000

Special Price USD 700

PAY BY INVOICE

Be the first to review this product

Table of Contents

PharmAsia Market Study May 2000, May 2000 Market Study - Respiratory Diseases in JapanOverview and ScopeOverview and ScopeMarket Engineering Analysis ofthe Japanese Bronchitis and AllergicCoryza Products Market (1996-2006)Market DefinitionsMarket Engineering Research Measurement SystemChallenges Facing the Bronchitis and Allergic Coryza Markets in JapanMarket Engineering Valuation and Revenue Forecasts (1996-2006)Marketing Engineering Research AnalysisMarketing Engineering Research AnalysisMarket ForecastsDemand AnalysisCompetitive StructureMarket Engineering Strategic Recommendations for Bronchitis and Allergic Coryza MarketMarket Engineering Strategic Recommendations for Bronchitis and Allergic Coryza MarketShift the Focus of Product Development from Broad-Based Antibiotics and Antibacterials to Specialized and Effective Drugs for BronchitisPenetrate the BronchodilatorsSegment by Targeting Patients with Mild BronchitisDevelop and Introduce Antibiotics with Different Chemical Functions; Preventive Drugs and Potentiating Agents for the Action of Other Antibiotics/AntibacterialsPenetrate the Influenza Vaccines and Anti-virus Drugs SegmentsTrigger Early Diagnosis of Chronic Bronchitis Patients by Encouraging the Government to Regulate Active Information Activities to Create AwarenessActivate Co-marketing with Other Pharmaceutical Companies to Share Costs for R&D and SalesProduce Generics for the Introduction of the Prospective Payment SystemDevelop Products for Allergic Coryza in OTC Segments and Co-sell the Products with Other Pharmaceutical Companies That Have Strong Distribution ChannelsDevelop Improved Anti-allergics to Compete with the Emerging Non-drug TherapiesDevelop Complementary Products for Non-drug Therapies Like Laser Surgery and Anti-anaphylaxis TherapyInnovate Current Anti-allergics and Reduce Impairment of Performance




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.